328: Pfizer's activist troubles, gene therapy questions, RFK Jr.'s MAHA ambitions
The Readout Loud
00:00
Intro
This chapter explores the latest movements in the biotech sector, particularly Starboard's activist campaign against Pfizer. It also delves into the challenges of Duchenne therapy assessments, Robert F. Kennedy Jr.'s health initiative, and Regeneron's innovative responses to modern clinical trial complexities.
Play episode from 00:00
Transcript
